Genetic Causes of Bronchiectasis

Clinics in Chest Medicine

Volumn 33, Issue 2, 2012, Pages 249-263

  Gould, Christine M ^a,b   Freeman, Alexandra F ^c   Olivier, Kenneth N ^c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Bronchiectasis; Congenital anomalies of the airway; Genetic; Immunodeficiency; Impaired mucociliary clearance

Indexed keywords

ALPHA 1 ANTITRYPSIN DEFICIENCY; AZOOSPERMIA; BRONCHIECTASIS; BRUTON THYROXIN KINASE GENE; CILIARY DYSKINESIA; CLINICAL FEATURE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE; DISEASE ACTIVITY; DYNEIN AXONEMAL HEAVY CHIAN 5 GENE; DYNEIN AXONEMAL INTERMEDIATE CHAIN 1 GENE; DYNEIN AXONEMAL INTERMEDIATE CHAIN 2 GENE; FIBRILLIN GENE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SCREENING; GENETIC VARIABILITY; GLUTATHIONE S TRANSFERASE GENE; HEREDITARY CONNECTIVE TISSUE DISEASE; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPER IGE SYNDROME; LUNG FUNCTION TEST; MANNOSE BINDING LECTIN 2 GENE; MIDDLE LUNG LOBE SYNDROME; MODIFIER GENE; MOLECULAR PATHOLOGY; MUCOCILIARY CLEARANCE; OUTER DYNEIN ARM GENE; PRIORITY JOURNAL; REVIEW; SERPINA1 GENE; THIOREDOXIN DOMAIN CONTAINING 3 GENE; TRACHEOBRONCHOMEGALY; TRANSFORMING GROWTH FACTOR BETA1 GENE; WILLIAMS BEUREN SYNDROME; X LINKED AGAMMAGLOBULINEMIA; YELLOW NAIL SYNDROME; YOUNG SYNDROME;

BRONCHIECTASIS; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, HUMORAL; MUCOCILIARY CLEARANCE;

EID: 84861538771     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2012.03.002     Document Type: Review

References (145)

1. Barker A. Bronchiectasis. N Engl J Med 2002, 346:1383-1393.
2. Callahan C.W., Redding G.J. Bronchiectasis in children: orphan disease or persistent problem?. Pediatr Pulmonol 2002, 33:492-496.
3. Lewitson N. Bronchiectasis. Pediatric respiratory disease 1993, 222-229. WB Saunders, Philadelphia. B. Hilman (Ed.).
4. Eastham K.M., Fall A.J., Mitchell L., et al. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax 2004, 59:324-327.
5. Edwards E.A., Asher M.I., Byrnes C.A. Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand. J Paediatr Child Health 2003, 39:111-117.
6. Kim H.Y., Kwon J.W., Seo J., et al. Bronchiectasis in children: 10-year experience at a single institution. Allergy Asthma Immunol Res 2011, 3(1):39-45.
7. Li A.M., Sonnappa S., Lex C., et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management?. Eur Respir J 2005, 26:8-14.
8. Twiss J., Metcalfe R., Edwards E., et al. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child 2005, 90:737-740.
9. Pasteur M., Helliwell S., Houghton J., et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000, 162:1277-1284.
10. Brodlie M., Spencer D.A. Bronchomalacia occurring in monozygotic twins-further information about its inheritance. Acta Paediatr 2009, 98(9):1531-1533.
11. Wong K.S., Lien R., Lin T.Y. Congenital tracheobronchial stenosis in monozygotic twins. Eur J Pediatr 1998, 157(12):1023-1025.
12. Abuhamad A.Z., Bass T., Katz M.E., et al. Familial recurrence of pulmonary sequestration. Obstet Gynecol 1996, 87(5):843-845.
13. Novak R.M. Laryngotracheoesophageal cleft and unilateral pulmonary hypoplasia in twins. Pediatrics 1981, 67(5):732-734.
14. Roth-Kleiner M., Post M. Genetic control of lung development. Biol Neonate 2003, 84(1):83-88.
15. Williams H., Cambell P. Generalized bronchiectasis associated with deficiency of cartilage in the bronchial tree. Arch Dis Child 1960, 35:182-191.
16. Williams H.E., Landau L.I., Phelan P.D. Generalized bronchiectasis due to extensive deficiency of bronchial cartilage. Arch Dis Child 1972, 47(253):423-428.
17. Wayne K.S., Taussig L.M. Probable familial congenital bronchiectasis due to cartilage deficiency (Williams-Campbell syndrome). Am Rev Respir Dis 1976, 114(1):15-22.
18. Jones V.F., Eid N.S., Franco S.M., et al. Familial congenital bronchiectasis: Williams-Campbell syndrome. Pediatr Pulmonol 1993, 16(4):263-267.
19. Hartman T.E., Primack S.L., Lee K.S., et al. CT of bronchial and bronchiolar diseases. Radiographics 1994, 14(5):991-1003.
20. George J., Jain R., Tariq S.M. CT bronchoscopy in the diagnosis of Williams-Campbell syndrome. Respirology 2006, 11(1):117-119.
21. Blake M.A., Clarke P.D., Fenlon H.M. Thoracic case of the day. Mounier-Kuhn syndrome (tracheobronchomegaly). J Thorac Imaging 1991, 6(2):1-10.
22. Ghanei M., Peyman M., Aslani J., et al. Mounier-Kuhn syndrome: a rare cause of severe bronchial dilatation with normal pulmonary function test: a case report. Respir Med 2007, 101(8):1836-1839.
23. Shin M.S., Jackson R.M., Ho K.J. Tracheobronchomegaly (Mounier-Kuhn syndrome): CT diagnosis. AJR Am J Roentgenol 1988, 150:777-779.
24. Schwartz M., Rossoff L. Tracheobronchomegaly. Chest 1994, 106:1589-1590.
25. Johnston R.F., Green R.A. Tracheobronchiomegaly. Report of five cases and demonstration of familial occurrence. Am Rev Respir Dis 1965, 91:35-50.
26. Aaby G.V., Blake H.A. Tracheobronchiomegaly. Ann Thorac Surg 1966, 2(1):64-70.
27. Woodring J.H., Howard R.S., Rehm S.R. Congenital tracheobronchomegaly (Mounier-Kuhn syndrome): a report of 10 cases and review of the literature. J Thorac Imaging 1991, 6(2):1-10.
28. Celik B., Bilgin S., Yuksel C. Mounier-Kuhn syndrome: a rare cause of bronchial dilation. Tex Heart Inst J 2011, 38(2):194-196.
29. Rosenstein B.J., Cutting G.R. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998, 132(4):589-595.
30. The cystic fibrosis mutation database. Available at: Accessed November 2011. http://www.genet.sickkids.on.ca/cftr/.
31. Castellani C., Cuppens H., Macek M., et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008, 7(3):179-196.
32. Dequeker E., Stuhrmann M., Morris M.A., et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders-updated European recommendations. Eur J Hum Genet 2009, 17(1):51-65.
33. Costa C., Pruliere-Escabasse V., de Becdelievre A., et al. A recurrent deep-intronic splicing CF mutation emphasizes the importance of mRNA studies in clinical practice. J Cyst Fibros 2011, 10(6):479-482.
34. Sly P.D., Brennan S., Gangell C., Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF), et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009, 180(2):146-152.
35. Cutting G.R. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci 2010, 1214:57-69.
36. Merlo C.A., Boyle M.P. Modifier genes in cystic fibrosis lung disease. J Lab Clin Med 2003, 141(4):237-241.
37. Noone P.G., Leigh M.W., Sannuti A., et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004, 169(4):459-467.
38. Akhurst R.J. TGF beta signaling in health and disease. Nat Genet 2004, 36(8):790-792.
39. Drumm M.L., Konstan M.W., Schluchter M.D., et al. Gene Modifier Study Group. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005, 353(14):1443-1453.
40. Bremer L.A., Blackman S.M., Vanscoy L.L., et al. Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum Mol Genet 2008, 17(14):2228-2237.
41. Wolfenden L.L., Schechter M.S. Genetic and non-genetic determinants of outcomes in cystic fibrosis. Paediatr Respir Rev 2009, 10(1):32-36.
42. Zariwala M.A., Knowles M.R., Leigh M.W. Primary ciliary dyskinesia. GeneReviews 1993, [Internet], University of Washington, Seattle (WA), January 24, 2007 [updated October 6, 2009]. R.A. Pagon, T.D. Bird, C.R. Dolan (Eds.).
43. Kapur N., Karadag B. Differences and similarities in non-cystic fibrosis bronchiectasis between developing and affluent countries. Paediatr Respir Rev 2011, 12(2):91-96.
44. Verra F., Escudier E., Bignon J., et al. Inherited factors in diffuse bronchiectasis in the adult: a prospective study. Eur Respir J 1991, 4(8):937-944.
45. Ellerman A., Bisgaard H. Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. Eur Respir J 1997, 10(10):2376-2379.
46. Marthin J.K., Petersen N., Skovgaard L.T., et al. Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study. Am J Respir Crit Care Med 2010, 181(11):1262-1268.
47. Zariwala M.A., Omran H., Ferkol T.W. The emerging genetics of primary ciliary dyskinesia. Proc Am Thorac Soc 2011, 8:430-433.
48. Leigh M.W., O'Callaghan C., Knowles M.R. The challenges of diagnosing primary ciliary dyskinesia. Proc Am Thorac Soc 2011, 8:434-437.
49. Loges N.T., Olbrich H., Becker-Heck A., et al. Deletions and point mutations of LRRC50 cause primary ciliary dyskinesia due to dynein arm defects. Am J Hum Genet 2009, 85(6):883-889.
50. Narayan D., Krishnan S.N., Upender M., et al. Unusual inheritance of primary ciliary dyskinesia (Kartagener's syndrome). J Med Genet 1994, 31(6):493-496.
51. Krawczyński M.R., Witt M. Pcd and RP: X-linked inheritance of both disorders?. Pediatr Pulmonol 2004, 38(1):88-89.
52. Bartoloni L., Blouin J.L., Pan Y., et al. Mutations in the DNAH11 (axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia. Proc Natl Acad Sci U S A 2002, 99(16):10282-10286.
53. Duriez B., Duquesnoy P., Escudier E., et al. A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia. Proc Natl Acad Sci U S A 2007, 104(9):3336-3341.
54. Loges N.T., Olbrich H., Fenske L., et al. DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm. Am J Hum Genet 2008, 83(5):547-558.
55. Zariwala M.A., Leigh M.W., Ceppa F., et al. Mutations of DNAI1 in primary ciliary dyskinesia: evidence of founder effect in a common mutation. Am J Respir Crit Care Med 2006, 174(8):858-866.
56. Hornef N., Olbrich H., Horvath J., et al. DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Am J Respir Crit Care Med 2006, 174(2):120-126.
57. Omran H., Kobayashi D., Olbrich H., et al. Ktu/PF13 is required for cytoplasmic pre-assembly of axonemal dyneins. Nature 2008, 456(7222):611-616.
58. Castleman V.H., Romio L., Chodhari R., et al. Mutations in radial spoke head protein genes RSPH9 and RSPH4A cause primary ciliary dyskinesia with central-microtubular-pair abnormalities. Am J Hum Genet 2009, 84(2):197-209.
59. Jorissen M., Willems T., Van der Schueren B., et al. Ultrastructural expression of primary ciliary dyskinesia after ciliogenesis in culture. Acta Otorhinolaryngol Belg 2000, 54:883-889.
60. Moore A., Escudier E., Roger G., et al. RPGR is mutated in patients with a complex X linked phenotype combining primary ciliary dyskinesia and retinitis pigmentosa. J Med Genet 2006, 43(4):326-333.
61. Budny B., Chen W., Omran H., et al. A novel X-linked recessive mental retardation syndrome comprising macrocephaly and ciliary dysfunction is allelic to oral-facial-digital type I syndrome. Hum Genet 2006, 120(2):171-178.
62. Leigh M.W. Primary ciliary dyskinesia. Disorders of the respiratory tract of children 2006, 902-909. Saunders-Elsevier, Philadelphia. V. Chernick, T.F. Boat, R.W. Wilmott (Eds.).
63. Davis S.D., Knowles M., Leigh M. Introduction: primary ciliary dyskinesia and overlapping syndromes. Proc Am Thorac Soc 2011, 8:421-422.
64. Coren M.E., Meeks M., Morrison I., et al. Primary ciliary dyskinesia: age at diagnosis and symptom history. Acta Paediatr 2002, 91(6):667-669.
65. Banjar H.H. A review of 151 cases of pediatric noncystic fibrosis bronchiectasis in a tertiary care center. Ann Thorac Med 2007, 2(1):3-8.
66. Inners C.R., Terry P.B., Traystman R.J., et al. Collateral ventilation and the middle lobe syndrome. Am Rev Respir Dis 1978, 118(2):305-310.
67. Einarsson J.T., Einarsson J.G., Isaksson H., et al. Middle lobe syndrome: a nationwide study on clinicopathological features and surgical treatment. Clin Respir J 2009, 3(2):77-81.
68. Priftis K.N., Anthracopoulos M.B., Mermiri D., et al. Bronchial hyperresponsiveness, atopy, and bronchoalveolar lavage eosinophils in persistent middle lobe syndrome. Pediatr Pulmonol 2006, 41(9):805-811.
69. Kwon K.Y., Myers J.L., Swensen S.J., et al. Middle lobe syndrome: a clinicopathological study of 21 patients. Hum Pathol 1995, 26(3):302-307.
70. Le Lannou D., Jezequel P., Blayau M., et al. Obstructive azoospermia with agenesis of vas deferens or with bronchiectasia (Young's syndrome): a genetic approach. Hum Reprod 1995, 10(2):338-341.
71. Friedman K.J., Teichtahl H., De Kretser D.M., et al. Screening Young syndrome patients for CFTR mutations. Am J Respir Crit Care Med 1995, 152(4 Pt 1):1353-1357.
72. Dees S.C., Spock A. Right middle lobe syndrome in children. JAMA 1966, 197(1):8-14.
73. Danielson G.K., Hanson C.W., Cooper E.C. Middle lobe bronchiectasis. Report of an unusual familial occurrence. JAMA 1967, 201(8):605-608.
74. Hoo J.J. Familial middle lobe bronchiectasis. Clin Genet 1979, 15(1):85-88.
75. Livingston G.L., Holinger L.D., Luck S.R. Right middle lobe syndrome in children. Int J Pediatr Otorhinolaryngol 1987, 13(1):11-23.
76. Takahashi H., Kimura S., Nagai I., et al. A case of middle lobe syndrome occurring in two sisters. Jpn J Surg 1990, 20(5):597-601.
77. Hendry W.F., A'Hern R.P., Cole P.J. Was Young's syndrome caused by exposure to mercury in childhood?. BMJ 1993, 307(6919):1579-1582.
78. Handelsman D.J., Conway A.J., Boylan L.M., et al. Young's syndrome. Obstructive azoospermia and chronic sinopulmonary infections. N Engl J Med 1984, 310(1):3-9.
79. de Iongh R., Ing A., Rutland J. Mucociliary function, ciliary ultrastructure, and ciliary orientation in Young's syndrome. Thorax 1992, 47(3):184-187.
80. Pryor J.P. Cystic fibrosis and Young's syndrome. Lancet 1998, 352(9133):1065. [author reply: 1065-6].
81. Dörk T., Dworniczak B., Aulehla-Scholz C., et al. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet 1997, 100(3-4):365-377.
82. Barker A.F., Craig S., Bardana E.J. Humoral immunity in bronchiectasis. Ann Allergy 1987, 59(3):179-182.
83. Goeminne P.C., Dupont L.J. The sinusitis-infertility syndrome: Young's saint, old devil. Eur Respir J 2010, 35(3):698.
84. Shoemark A., Ozerovitch L., Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med 2007, 101(6):1163-1170.
85. Arya A.K., Beer H.L., Benton J., et al. Does Young's syndrome exist?. J Laryngol Otol 2009, 123(5):477-481.
86. Broides A., Yang W., Conley M.E. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol 2006, 118(2-3):195-200.
87. Buckley R.H. Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev 2004, 5(Suppl A):S225-S233.
88. Nikolaizik W.H., Warner J.O. Aetiology of chronic suppurative lung disease. Arch Dis Child 1994, 70(2):141-142.
89. Cazzola G., Valletta E.A., Ciaffoni S., et al. Neutrophil function and humoral immunity in children with recurrent infections of the lower respiratory tract and chronic bronchial suppuration. Ann Allergy 1989, 63(3):213-218.
90. Conley M.E., Dobbs A.K., Farmer D.M., et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 2009, 27:199-227.
91. Freeman A.F., Holland S.M. Antimicrobial prophylaxis for primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2009, 9(6):525-530.
92. Boyton R.J., Smith J., Jones M., et al. Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clin Exp Immunol 2008, 152(1):95-101.
93. Boyton R.J. Regulation of immunity in bronchiectasis. Med Mycol 2009, 47(Suppl 1):S175-S182.
94. Moreau T., Calmels B., Barlogis V., et al. Potential application of gene therapy to X-linked agammaglobulinemia. Curr Gene Ther 2007, 7(4):284-294.
95. Scharenberg A.M., Hannibal M.C., Torgerson T., et al. Common variable immune deficiency overview. GeneReviews 1993, [Internet], University of Washington, Seattle (WA), Updated July 5, 2006. R.A. Pagon, T.D. Bird, C.R. Dolan (Eds.).
96. Notarangelo L.D., Plebani A., Mazzolari E., et al. Genetic causes of bronchiectasis: primary immune deficiencies and the lung. Respiration 2007, 74(3):264-275.
97. Dosanjh A. Chronic pediatric pulmonary disease and primary humoral antibody based immune disease. Respir Med 2011, 105(4):511-514.
98. Loeys B., De Backer J., Van Acker P., et al. Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome. Hum Mutat 2004, 24(2):140-146.
99. Aghamohammadi A., Allahverdi A., Abolhassan H., et al. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology 2010, 15(2):289-295.
100. Carsetti R., Rosado M.M., Donnanno S., et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005, 115(2):412-417.
101. Kralovicova J., Hammarström L., Plebani A., et al. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J Immunol 2003, 170(5):2765-2775.
102. Deane S., Selmi C., Naguwa S.M., et al. Common variable immunodeficiency: etiological and treatment issues. Int Arch Allergy Immunol 2009, 150(4):311-324.
103. Freeman A.F., Holland S.M. The hyper-IgE syn-dromes. Immunol Allergy Clin North Am 2008, 28(2):277-291. viii.
104. Holland S.M., DeLeo F.R., Elloumi H.Z., et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007, 357:1608-1619.
105. Dinwiddle R., Sonnappa S. Systemic diseases of the lung. Paediatr Respir Rev 2005, 6(3):181-189.
106. Lynch D.A. Lung disease related to collagen vascular disease. J Thorac Imaging 2009, 24(4):299-309.
107. Shin M.S., Ho K.J. Bronchiectasis in patients with alpha 1-antitrypsin deficiency. A rare occurrence?. Chest 1993, 104(5):1384-1386.
108. Neptune E.R., Frischmeyer P.A., Arking D.E., et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003, 33(3):407-411.
109. Stoller J.K., Aboussouan L.S. alpha1-Antitrypsin deficiency. 5: intravenous augmentation therapy: current understanding. Thorax 2004, 59(8):708-712.
110. Dietz H.C. Marfan syndrome. GeneReviews 1993, [Internet], University of Washington, Seattle, Seattle (WA), April 18, 2001 [updated June 30, 2009]. R.A. Pagon, T.D. Bird, C.R. Dolan (Eds.).
111. Furtado L.V., Wooderchak-Donahue W., Rope A.F., et al. Characterization of large genomic deletions in the FBN1 gene using multiplex ligation-dependent probe amplification. BMC Med Genet 2011, 12(1):119.
112. Callewaert B.L., Loeys B.L., Ficcadenti A., et al. Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of literature. Hum Mutat 2009, 30(3):334-341.
113. Mizuguchi T., Collod-Beroud G., Akiyama T., et al. Heterozygous TGFBR2 mutations in Marfan's syndrome. Nat Genet 2004, 36(8):855-860.
114. Loeys B.L., Chen J., Neptune E.R., et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 and TGFBR2. Nat Genet 2005, 37(3):275-281.
115. Mizuguchi T., Matsumoto N. Recent progress in genetics of Marfan syndrome and Marfan-associated disorders. J Hum Genet 2007, 52(1):1-12.
116. Stheneur C., Collod-Béroud G., Faivre L., et al. Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders. Hum Mutat 2008, 29(11):E284-E295.
117. Chaudhry S.S., Cain S.A., Morgan A., et al. Fibrillin-1 regulates the bioavailability of TGFbeta1. J Cell Biol 2007, 176:355-367.
118. Yeowell H.N., Steinmann B. Ehlers-Danlos syndrome, kyphoscoliotic form. GeneReviews 1993, [Internet], University of Washington, Seattle (WA), February 2, 2000 [updated February 19, 2008]. R.A. Pagon, T.D. Bird, C.R. Dolan (Eds.).
119. Pepin M.G., Byers P.H. Ehlers-Danlos syndrome type IV. GeneReviews 1993, [Internet], University of Washington, Seattle (WA), September 2, 1999 [updated May 3, 2011]. R.A. Pagon, T.D. Bird, C.R. Dolan (Eds.).
120. Pepin M., Schwarze U., Superti-Furga A., et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000, 342(10):673-680.
121. Yeowell H.N., Walker L.C., Farmer B., et al. Mutational analysis of the lysyl hydroxylase 1 gene (PLOD) in six unrelated patients with Ehlers-Danlos syndrome type VI: prenatal exclusion of this disorder in one family. Hum Mutat 2000, 16(1):90.
122. Stoller J.K., Aboussouan L.S. Alpha1-antitrypsin deficiency. Lancet 2005, 365(9478):2225-2236.
123. Köhnlein T., Welte T. Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment. Am J Med 2008, 121(1):3-9.
124. Beer D.J., Pereira W., Snider G.L. Pleural effusion associated with primary lymphedema: a perspective on the yellow nail syndrome. Am Rev Respir Dis 1978, 117(3):595-599.
125. Silverman E.K., Sandhaus R.A. Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med 2009, 360(26):2749-2757.
126. Bull R.H., Fenton D.A., Mortimer P.S. Lymphatic function in the yellow nail syndrome. Br J Dermatol 1996, 134(2):307-312.
127. Guest P.J., Hansell D.M. High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol 1992, 45(4):260-266.
128. King M.A., Stone J.A., Diaz P.T., et al. Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996, 199(1):137-141.
129. Dirksen A., Dijkman J.H., Madsen F., et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999, 160(5 Pt 1):1468-1472.
130. Greene C.M., McElvaney N.G. Protein misfolding and obstructive lung disease. Proc Am Thorac Soc 2010, 7(6):346-355.
131. Greene C.M., Hassan T., Molloy K., et al. The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency. Expert Rev Respir Med 2011, 5(3):395-411.
132. Cuvelier A., Muir J.F., Hellot M.F., et al. Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis. Chest 2000, 117(2):415-419.
133. Rodriguez-Cintron W., Guntupalli K., Fraire A.E. Bronchiectasis and homozygous (P1ZZ) alpha 1-antitrypsin deficiency in a young man. Thorax 1995, 50(4):424-425.
134. Longstreth G.F., Weitzman S.A., Browning R.J., et al. Bronchiectasis and homozygous alpha1-antitrypsin deficiency. Chest 1975, 67(2):233-235.
135. Talmud P.J., Martin S., Steiner G., et al. Diabetes Atherosclerosis Intervention Study Investigators. Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. Arterioscler Thromb Vasc Biol 2003, 23(4):644-649.
136. Quint J.K., Donaldson G.C., Kumari M., et al. SERPINA1 11478G→A variant, serum α1-antitrypsin, exacerbation frequency and FEV1 decline in COPD. Thorax 2011, 66(5):418-424.
137. Wood A.M., Simmonds M.J., Bayley D.L., et al. The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency. Respir Res 2008, 9:52.
138. Demeo D.L., Campbell E.J., Barker A.F., et al. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol 2008, 38(1):114-120.
139. Maldonado F., Tazelaar H.D., Wang C.W., et al. Yellow nail syndrome: analysis of 41 consecutive patients. Chest 2008, 134(2):375-381.
140. Battaglia A., di Ricco G., Mariani G., et al. Pleural effusion and recurrent broncho-pneumonia with lymphedema, yellow nails and protein-losing enteropathy. Eur J Respir Dis 1985, 66(1):65-69.
141. D'Alessandro A., Muzi G., Monaco A., et al. Yellow nail syndrome: does protein leakage play a role?. Eur Respir J 2001, 17(1):149-152.
142. Miro A.M., Vasudevan V., Shah H. Ciliary motility in two patients with yellow nail syndrome and recurrent sinopulmonary infections. Am Rev Respir Dis 1990, 142(4):890-891.
143. Bokszczanin A., Levinson A.I. Coexistent yellow nail syndrome and selective antibody deficiency. Ann Allergy Asthma Immunol 2003, 91(5):496-500.
144. Wiggins J., Strickland B., Chung K.F. Detection of bronchiectasis by high-resolution computed tomography in the yellow nail syndrome. Clin Radiol 1991, 43(6):377-379.
145. Hoque S.R., Mansour S., Mortimer P.S. Yellow nail syndrome: not a genetic disorder? Eleven new cases and a review of the literature. Br J Dermatol 2007, 156(6):1230-1234.